1. Home
  2. TLSA vs STCN Comparison

TLSA vs STCN Comparison

Compare TLSA & STCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TLSA
  • STCN
  • Stock Information
  • Founded
  • TLSA 2013
  • STCN 1986
  • Country
  • TLSA United Kingdom
  • STCN United States
  • Employees
  • TLSA N/A
  • STCN N/A
  • Industry
  • TLSA Biotechnology: Pharmaceutical Preparations
  • STCN Advertising
  • Sector
  • TLSA Health Care
  • STCN Consumer Discretionary
  • Exchange
  • TLSA Nasdaq
  • STCN Nasdaq
  • Market Cap
  • TLSA 87.8M
  • STCN 63.4M
  • IPO Year
  • TLSA 2000
  • STCN 1994
  • Fundamental
  • Price
  • TLSA $1.20
  • STCN $10.40
  • Analyst Decision
  • TLSA
  • STCN
  • Analyst Count
  • TLSA 0
  • STCN 0
  • Target Price
  • TLSA N/A
  • STCN N/A
  • AVG Volume (30 Days)
  • TLSA 145.8K
  • STCN 11.9K
  • Earning Date
  • TLSA 05-10-2024
  • STCN 12-12-2024
  • Dividend Yield
  • TLSA N/A
  • STCN N/A
  • EPS Growth
  • TLSA N/A
  • STCN 203.29
  • EPS
  • TLSA N/A
  • STCN 3.17
  • Revenue
  • TLSA N/A
  • STCN $169,044,000.00
  • Revenue This Year
  • TLSA N/A
  • STCN N/A
  • Revenue Next Year
  • TLSA N/A
  • STCN N/A
  • P/E Ratio
  • TLSA N/A
  • STCN $3.19
  • Revenue Growth
  • TLSA N/A
  • STCN N/A
  • 52 Week Low
  • TLSA $0.41
  • STCN $7.36
  • 52 Week High
  • TLSA $1.74
  • STCN $13.00
  • Technical
  • Relative Strength Index (RSI)
  • TLSA 65.44
  • STCN 57.19
  • Support Level
  • TLSA $0.83
  • STCN $9.90
  • Resistance Level
  • TLSA $0.92
  • STCN $10.29
  • Average True Range (ATR)
  • TLSA 0.09
  • STCN 0.39
  • MACD
  • TLSA 0.03
  • STCN 0.11
  • Stochastic Oscillator
  • TLSA 84.52
  • STCN 100.00

About TLSA Tiziana Life Sciences Ltd.

Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in the developing transformative therapies for neurodegenerative and lung diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.

About STCN Steel Connect Inc.

Steel Connect Inc is a diversified holding company. The company's operating segment include Direct Marketing and Supply Chain. It generates maximum revenue from the Direct Marketing segment. Geographically, it derives a majority of revenue from the United States and also has a presence in China; Netherlands, and others. The company serves clients in various industries including consumer electronics, communications, computing, software, storage, and retail industries.

Share on Social Networks: